Navigation Links
GELase LMT Agarose Gel-Digesting Preparation from EPICENTRE Biotechnologies

ProductsGELase LMT Agarose Gel-Digesting Preparation from EPICENTRE Biotechnologies
Company EPICENTRE Biotechnologies
Item GELase LMT Agarose Gel-Digesting Preparation
Price $125.00
Description GELase™ Agarose Gel-Digesting Preparation contains a unique β-agarose digesting enzyme developed at EPICENTRE for simple, quantitative recovery of intact DNA and RNA from low melting point (LMP) agarose gels following electrophoresis in TAE, TBE, MOPS, or phosphate buffers. The gel may be digested directly in the TAE, TBE, MOPS, and phosphate electrophoresis buffers or GELase™ Buffer may be added to or exchanged with those buffers for higher activity. GELase Preparation digests the carbohydrate backbone of molten agarose, releasing small, soluble oligosaccharides. The nucleic acid can be used in the digested gel solution or precipitated using ammonium acetate/ethanol. The gel digestion products are alcohol soluble.
Info EPICENTRE BiotechnologiesEPICENTRE Biotechnologies
726 Post Road
Madison, WI 53713
USA
Customer Service: 800-284-8474
Tech Support: 800-284-8474
Fax Number: 608-442-6114
Web Site: http://www.epibio.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GELase LMP Agarose Gel-Digesting Preparation from EPICENTRE Biotechnologies
2. GELase LMP Agarose Gel-Digesting Preparation from EPICENTRE Biotechnologies
3. GELase LMT Agarose Gel-Digesting Preparation from EPICENTRE Biotechnologies
4. GELase LMT Agarose Gel-Digesting Preparation from EPICENTRE Biotechnologies
5. GELase 50X Reaction Buffer from EPICENTRE Biotechnologies
6. S-Protein Agarose from Novagen
7. S-Protein Agarose from Novagen
8. S-Protein Agarose from Novagen
9. UltraPure Agarose and SYBR Safe DNA Gel Stain Combo from Invitrogen
10. UltraPure Agarose and SYBR Safe DNA Gel Stain combo from Invitrogen
11. ReadyPrep Overlay Agarose, 50 ml from Bio-Rad
Polyclonal Antibody to PRG3...
IRF7 Immunogen: Synthetic peptide corresponding to residues E(463) G T Q R E G V S S L D S S S(477) of human IRF7. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Purified anti-PI3K p110 delta...
Peptide-affinity Purified Polyclonal Antibody to Retinoic Acid-Induced 3 (RAI3/RAIG1)...
Biology Products:
(Date:3/15/2016)... 2016 --> --> ... Market Research "Digital Door Lock Systems Market - Global Industry ... the global digital door lock systems market in terms of ... is forecast to grow at a CAGR of 31.8% during ... medium enterprises (MSMEs) across the world and high industrial activity ...
(Date:3/14/2016)... HANOVER , Allemagne, March 14, 2016 /PRNewswire/ ... http://www.apimages.com ) - --> - ... ) - --> ... les solutions biométriques, fournit de nouveaux lecteurs d,empreintes ... lecteur LF10 de DERMALOG sera utilisé pour produire ...
(Date:3/10/2016)... March 10, 2016 --> ... research report "Identity and Access Management Market by Component ... and Governance), by Organization Size, by Deployment, by Vertical, ... by MarketsandMarkets, The market is estimated to grow from ... by 2020, at a Compound Annual Growth Rate (CAGR) ...
Breaking Biology News(10 mins):
(Date:4/26/2016)... ... April 26, 2016 , ... BioFactura, Inc ., a biopharmaceutical ... of financing. Healthy investor interest drove significant oversubscription of the original $1.5M target. ... as biosimilars, to the advanced preclinical stages. , Chief Executive Officer and President, ...
(Date:4/26/2016)... VIENNA and MIAMI ... The prize recognizes the innovation capabilities of ... that will benefit patients and laboratory diagnostics globally. ... , Norma Instruments , an ... products in the field of hematology, announced today ...
(Date:4/26/2016)... ... 26, 2016 , ... The Institute for Venture Science (IVS), ... pre-proposal competition for scientific grants. , The IVS funds promising ideas that challenge ... potential to replace paradigms that have outlived their usefulness. All areas of natural ...
(Date:4/26/2016)... , April 26, 2016 Celsion ... development company, today announced that the first patient ... enrolled in its ongoing global Phase III OPTIMA ... of doxorubicin, in combination with radiofrequency ablation standardized ... treat newly diagnosed patients with primary liver cancer, ...
Breaking Biology Technology: